Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 25122-47-8
2. N51w309113
3. Unii-n51w309113
4. Eumosone
5. Schembl565893
6. Zinc31333022
7. Q27284562
8. (11.beta.,16.beta.)-21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxobutoxy)pregna-1,4-diene-3,20-dione
9. Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxobutoxy)-, (11.beta.,16.beta.)-
10. Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxobutoxy)-, (11beta,16beta)-
| Molecular Weight | 481.0 g/mol |
|---|---|
| Molecular Formula | C26H34ClFO5 |
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 480.2078800 g/mol |
| Monoisotopic Mass | 480.2078800 g/mol |
| Topological Polar Surface Area | 80.7 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 945 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Market Place
ABOUT THIS PAGE
A Clobetasol Butyrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clobetasol Butyrate, including repackagers and relabelers. The FDA regulates Clobetasol Butyrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clobetasol Butyrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clobetasol Butyrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clobetasol Butyrate supplier is an individual or a company that provides Clobetasol Butyrate active pharmaceutical ingredient (API) or Clobetasol Butyrate finished formulations upon request. The Clobetasol Butyrate suppliers may include Clobetasol Butyrate API manufacturers, exporters, distributors and traders.
click here to find a list of Clobetasol Butyrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clobetasol Butyrate written confirmation (Clobetasol Butyrate WC) is an official document issued by a regulatory agency to a Clobetasol Butyrate manufacturer, verifying that the manufacturing facility of a Clobetasol Butyrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Clobetasol Butyrate APIs or Clobetasol Butyrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Clobetasol Butyrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Clobetasol Butyrate suppliers with Written Confirmation (WC) on PharmaCompass.
Clobetasol Butyrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clobetasol Butyrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clobetasol Butyrate GMP manufacturer or Clobetasol Butyrate GMP API supplier for your needs.
A Clobetasol Butyrate CoA (Certificate of Analysis) is a formal document that attests to Clobetasol Butyrate's compliance with Clobetasol Butyrate specifications and serves as a tool for batch-level quality control.
Clobetasol Butyrate CoA mostly includes findings from lab analyses of a specific batch. For each Clobetasol Butyrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clobetasol Butyrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Clobetasol Butyrate EP), Clobetasol Butyrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clobetasol Butyrate USP).
LOOKING FOR A SUPPLIER?
